Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Deanxit plus sertraline for somatic disease with comorbid depressive disorder
ChiCTR-TRC-11001732Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of flupentixol + melitracen and sertraline in major depressive disorder (MDD) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Hamilton Depression Scale and Hamilton Anxiety Scale. Started Aug 2010; status: completed.
02
Drugs
flupentixol + melitracensertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001732.